|
National Stock Number(NSN): 6505-01-313-1824 (6505013131824, 013131824)
| NIIN: |
01-313-1824 |
Item Name: |
METAPROTERENOL SULFATE INHALATION AEROSOL |
INC: |
37614
|
| FSC: |
6505
|
Assignment Date: |
Jan-03-1990 |
CRIT: |
N |
IIG: |
37614 |
| ISC: |
5 |
Date Standardized: |
Jan-03-1990 |
HMIC: |
P |
DODIC: |
|
| NSC: |
5 |
Cancellation Date: |
Jul-01-2002 |
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
A |
DEMIL INT: |
|
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| NIIN: |
01-116-9245 |
Item Name: |
ALBUTEROL INHALATION AEROSOL |
| FSC: |
6505 |
Replacement Date: |
Jul-01-2002 |
|
INC: |
35772 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
9-1030 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
ALUPENT REFILL |
55391
|
BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
H |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
METAPREL REFILL |
04520
|
NOVARTIS PHARMACEUTICALS CORPORATION |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00078-0209-53 |
04520
|
NOVARTIS PHARMACEUTICALS CORPORATION |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00597-0070-18 |
55391
|
BOEHRINGER INGELHEIM PHARMACEUTICALS INC |
H |
3 |
2 |
4 |
54 |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
S9M |
L |
|
M |
U |
1 |
A |
$19.43 |
EA |
|
C2201X- |
May-01-1996 |
H |
| DF |
JDC |
L |
|
M |
U |
1 |
F |
$19.43 |
EA |
|
------- |
May-01-1996 |
H |
| DM |
JDC |
L |
Z |
M |
U |
1 |
M |
$19.43 |
EA |
|
1-54--- |
May-01-1996 |
H |
| DN |
JDC |
L |
|
M |
U |
1 |
N |
$19.43 |
EA |
|
9L----- |
May-01-1996 |
H |
| DS |
JDC |
L |
|
M |
U |
1 |
D |
$19.43 |
EA |
|
------- |
May-01-1996 |
H |
| VA |
JVS |
I |
|
M |
U |
B |
V |
$0.00 |
EA |
|
------- |
Jul-01-1991 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
R |
REFER TO NOT YET AVAIL |
000 |
|
|
|
| DM |
R |
REFER TO NOT YET AVAILABLE |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
15.000 MILLIGRAMS METAPROTERENOL SULFATE PER MILLILITER |
| CQCT |
PRIMARY CONTAINER TYPE |
ANY ACCEPTABLE |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
10.000 MILLILITERS |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
ALUPENT REFILL |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
8.525 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
0.416 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
72 |
| FEAT |
SPECIAL FEATURES |
MICRONIZED; SHALL DELIVER AT LEAST 200 SINGLE ORAL INHALATIONS OF 0.65 MG ACTIVE INGREDIENT PER METERED DOSE; FOR USE AS A REFILL FOR NSN 6505-01-311-8441 |
| SUCB |
UNIT OF ISSUE CUBE |
0.006 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.118 POUNDS |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
Jul-14-2000 |
3 |
H |
|
|
|
|
| FSKX |
|
Jul-14-2000 |
3 |
H |
|
|
|
|
| MC15 |
|
Jul-14-2000 |
3 |
H |
|
|
|
|
| N9LM |
|
Jul-14-2000 |
3 |
H |
|
|
|
|
| V542 |
|
Apr-01-1991 |
0 |
0 |
|
|
54 |
54 |
|